Global Lyophilization Contract Manufacturing Services (CDMO) Market Growth (Status and Outlook) 2023-2029

Global Lyophilization Contract Manufacturing Services (CDMO) Market Growth (Status and Outlook) 2023-2029

The global Lyophilization Contract Manufacturing Services (CDMO) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Lyophilization Contract Manufacturing Services (CDMO) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Lyophilization Contract Manufacturing Services (CDMO) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Lyophilization Contract Manufacturing Services (CDMO) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Lyophilization Contract Manufacturing Services (CDMO) players cover Thermo Fisher Scientific Inc., Ascendia Pharmaceuticals, PCI Pharma Services, Ellab, Lyophilization Technology,Inc., Lundbeck, LSNE Con​​tract Manufacturing, Pfizer and Jubilant Pharmova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Lyophilization is a process that removes moisture from a product while preserving its original chemical properties. Also known as freeze drying, this process is used in the production of many products, such as pharmaceuticals, biologics, food additives, and nutraceuticals. Lyophilization helps to reduce spoilage and extend the shelf life of a product, making it more stable and easier to transport.Pharmaceutical companies use lyophilization to make lyophilized injections, eye drops, other sensitive drugs, and parenteral dosage forms that cannot be manufactured through traditional methods. In the biopharmaceutical industry, lyophilization is used to preserve proteins and peptides for long-term storage, giving unstable biologics the shelf life and stability for more widespread distribution and use.

Lyophilization contract manufacturing services are beneficial for pharmaceutical and biopharmaceutical companies who lack the necessary resources and expertise to produce their own lyophilized products. Lyophilization is a meticulous process, but with experienced professionals to help guide the way, an effective lyophilized drug can be produced in a short amount of time.



LPI (LP Information)' newest research report, the “Lyophilization Contract Manufacturing Services (CDMO) Industry Forecast” looks at past sales and reviews total world Lyophilization Contract Manufacturing Services (CDMO) sales in 2022, providing a comprehensive analysis by region and market sector of projected Lyophilization Contract Manufacturing Services (CDMO) sales for 2023 through 2029. With Lyophilization Contract Manufacturing Services (CDMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lyophilization Contract Manufacturing Services (CDMO) industry.

This Insight Report provides a comprehensive analysis of the global Lyophilization Contract Manufacturing Services (CDMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lyophilization Contract Manufacturing Services (CDMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lyophilization Contract Manufacturing Services (CDMO) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lyophilization Contract Manufacturing Services (CDMO) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lyophilization Contract Manufacturing Services (CDMO).

This report presents a comprehensive overview, market shares, and growth opportunities of Lyophilization Contract Manufacturing Services (CDMO) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Formulation&Process Development
Lyophilization
Clinical Supply Manufacturing
Commercial Manufacturing
Storage&Distribution
Analytical Services

Segmentation by application
Pharmaceutical Company
Biotechnology Company
Generic Company

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc.
Ascendia Pharmaceuticals
PCI Pharma Services
Ellab
Lyophilization Technology,Inc.
Lundbeck
LSNE Con​​tract Manufacturing
Pfizer
Jubilant Pharmova
CARBOGEN AMCIS
Lubrizol Life Science
Recipharm AB
Berkshire Sterile Manufacturing
AbbVie
Zenvision Pharma LLP
Eurofins
COC Farmaceutici
Leadgene Biomedical,Inc.
Liof Pharma
Argonaut Manufacturing Services
Societal CDMO
PharmTech
Oakwood Labs
IDT Biologika
EMCM

Please note: The report will take approximately 2 business days to prepare and deliver.